VARYTEX Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.05M
- Investors
-
6
VARYTEX General Information
Description
Operator of Chinese medicine drugstores intended to provide online consultation and sales of Chinese herbal medicine. The company's platform helps in treatment by suggesting kampo medicine examination methods and proper kampo medicine usage, enabling doctors to provide proper diagnosis and treatment.
Contact Information
Website
www.varytex.co.jpCorporate Office
- 1st Floor, Roppongi Adachi Building
- 3-4-24 Roppongi, Minato-ku
- Tokyo, 106-0032
- Japan
Corporate Office
- 1st Floor, Roppongi Adachi Building
- 3-4-24 Roppongi, Minato-ku
- Tokyo, 106-0032
- Japan
VARYTEX Timeline
VARYTEX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 17-Apr-2024 | $1.05M | Completed | Generating Revenue | ||
| 1. Seed Round | 23-Jan-2023 | Completed | Generating Revenue |
VARYTEX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed A | ||||||||
| A-2 | ||||||||
| Seed A-1 | 218 | $1260.11 | $1260.11 | 1x | $1260.11 | 11.69% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
VARYTEX Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mobile Internet Capital | Venture Capital | Minority | ||
| MSD Corporate Investment | PE/Buyout | Minority | ||
| PKSHA Algorithm Fund | Venture Capital | Minority | ||
| SMBC Venture Capital | Corporate Venture Capital | Minority | ||
| Glanz Co., Ltd. | Venture Capital | Minority |
VARYTEX Acquisitions (1)
VARYTEX’s most recent deal was a Merger/Acquisition with Watashi Kampo. The deal was made on 01-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Watashi Kampo | 01-Apr-2026 | Merger/Acquisition | Clinics/Outpatient Services |
VARYTEX Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Watashi Kampo | Tokyo, Japan | 2017 |
VARYTEX FAQs
-
When was VARYTEX founded?
VARYTEX was founded in 2021.
-
Where is VARYTEX headquartered?
VARYTEX is headquartered in Tokyo, Japan.
-
What industry is VARYTEX in?
VARYTEX’s primary industry is Drug Delivery.
-
Is VARYTEX a private or public company?
VARYTEX is a Private company.
-
What is the current valuation of VARYTEX?
The current valuation of VARYTEX is .
-
What is VARYTEX’s current revenue?
The current revenue for VARYTEX is .
-
How much funding has VARYTEX raised over time?
VARYTEX has raised $1.45M.
-
Who are VARYTEX’s investors?
Mobile Internet Capital, MSD Corporate Investment, PKSHA Algorithm Fund, SMBC Venture Capital, and Glanz Co., Ltd. are 5 of 6 investors who have invested in VARYTEX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
